UBQLN3 — Ubiquilin 3

UBQLN3 — Ubiquilin 3

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">UBQLN3</th></tr>
<tr><th>Symbol</th><td>UBQLN3</td></tr>
<tr><th>Full Name</th><td>Ubiquilin 3</td></tr>
<tr><th>Chromosome</th><td>Xp11.23</td></tr>
<tr><th>NCBI Gene ID</th><td>[50628](https://www.ncbi.nlm.nih.gov/gene/50628)</td></tr>
<tr><th>OMIM</th><td>[301052](https://www.omim.org/entry/301052)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000166394](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166394)</td></tr>
<tr><th>UniProt</th><td>[Q9H7D9](https://www.uniprot.org/uniprot/Q9H7D9)</td></tr>
<tr><th>Associated Diseases</th><td>[Amyotrophic lateral sclerosis](/diseases/als), [Frontotemporal dementia](/diseases/frontotemporal-dementia), [Parkinson's disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Overview

UBQLN3 (Ubiquilin 3) is a member of the ubiquilin family of proteins that play critical roles in [protein quality control](/mechanisms/protein-quality-control-network). Originally identified as a protein involved in cellular proteostasis, UBQLN3 shares structural and functional features with other ubiquilins ([UBQLN1](/genes/ubqln1), [UBQLN2](/genes/ubqln2)) and has been implicated in [amyotrophic lateral sclerosis](/diseases/als) (ALS) and [frontotemporal dementia](/diseases/frontotemporal-dementia) (FTD) pathogenesis [fecto2011](https://pubmed.ncbi.nlm.nih.gov/21856688/).

UBQLN3 — Ubiquilin 3

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">UBQLN3</th></tr>
<tr><th>Symbol</th><td>UBQLN3</td></tr>
<tr><th>Full Name</th><td>Ubiquilin 3</td></tr>
<tr><th>Chromosome</th><td>Xp11.23</td></tr>
<tr><th>NCBI Gene ID</th><td>[50628](https://www.ncbi.nlm.nih.gov/gene/50628)</td></tr>
<tr><th>OMIM</th><td>[301052](https://www.omim.org/entry/301052)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000166394](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166394)</td></tr>
<tr><th>UniProt</th><td>[Q9H7D9](https://www.uniprot.org/uniprot/Q9H7D9)</td></tr>
<tr><th>Associated Diseases</th><td>[Amyotrophic lateral sclerosis](/diseases/als), [Frontotemporal dementia](/diseases/frontotemporal-dementia), [Parkinson's disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Overview

UBQLN3 (Ubiquilin 3) is a member of the ubiquilin family of proteins that play critical roles in [protein quality control](/mechanisms/protein-quality-control-network). Originally identified as a protein involved in cellular proteostasis, UBQLN3 shares structural and functional features with other ubiquilins ([UBQLN1](/genes/ubqln1), [UBQLN2](/genes/ubqln2)) and has been implicated in [amyotrophic lateral sclerosis](/diseases/als) (ALS) and [frontotemporal dementia](/diseases/frontotemporal-dementia) (FTD) pathogenesis [fecto2011](https://pubmed.ncbi.nlm.nih.gov/21856688/).

The ubiquilin family serves as molecular shuttles that deliver ubiquitinated proteins to the [proteasome](/mechanisms/proteasome-function) for degradation, bridging the gap between protein aggregation and clearance pathways [chang2015](https://pubmed.ncbi.nlm.nih.gov/25519961/). While UBQLN3 is less studied than its counterparts, it represents an important component of the [protein quality control network](/mechanisms/protein-quality-control-network) in neurons.

Gene and Protein Structure

Gene Organization

The UBQLN3 gene is located on chromosome Xp11.23 and encodes a protein of 642 amino acids with a molecular weight of approximately 71 kDa. The gene structure consists of multiple exons that encode the characteristic ubiquilin protein domains.

Protein Domains

The UBQLN3 protein contains the hallmark domains of the ubiquilin family [ko2017](https://pubmed.ncbi.nlm.nih.gov/28258510/):

Protein-Protein Interactions

UBQLN3 participates in protein quality control networks through interactions with:

| Partner | Interaction | Function |
|---------|-------------|----------|
| Proteasome | Ubl domain binding | Substrate delivery |
| Ubiquitinated proteins | UBA domain binding | Cargo recognition |
| Hsp70/Hsp90 | TPR domain | Chaperone interaction |
| UBQLN2 | Homologous | Potential complex formation |
| TDP-43 | Indirect | ALS pathology interaction |

Function in Protein Quality Control

Proteasome-Mediated Degradation

UBQLN3 functions as a molecular adaptor that delivers ubiquitinated proteins to the [proteasome](/mechanisms/proteasome-function) [matsumoto2013](https://pubmed.ncbi.nlm.nih.gov/24316977/):

The pathway operates as follows:

Autophagy Regulation

Beyond proteasome-mediated degradation, ubiquilins participate in [autophagy](/mechanisms/autophagy) pathways [kim2019](https://pubmed.ncbi.nlm.nih.gov/31120083/):

• Aggregate clearance: UBQLN3 may help deliver protein aggregates to autophagosomes
• Chaperone-mediated autophagy: May interface with selective autophagy receptors
• Lysosomal delivery: Coordinates with endosomal/lysosomal pathways

Protein Aggregation Dynamics

UBQLN3 influences [protein aggregation](/mechanisms/protein-aggregation-neurodegeneration) in neurons:

• Sequestration: Can bind to aggregation-prone proteins, potentially sequestering them
• Co-aggregation: May co-aggregate with disease proteins in inclusions
• Clearance competition: May compete with autophagy and proteasome pathways

Role in Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis

UBQLN3 is implicated in [ALS](/diseases/als) through multiple mechanisms [kakihana2021](https://pubmed.ncbi.nlm.nih.gov/33404036/), [chen2021](https://pubmed.ncbi.nlm.nih.gov/33231308/):

Genetic Evidence

• UBQLN2 mutations (related family member) cause X-linked ALS/FTD [deng2011](https://pubmed.ncbi.nlm.nih.gov/21859956/)
• UBQLN3 variants have been identified in some ALS patients [gkazi2019](https://pubmed.ncbi.nlm.nih.gov/31563806/)
• The UBQLN2-ALS connection strongly implicates ubiquilin dysfunction in disease

Proteasome Impairment

ALS is characterized by proteasome dysfunction:

• UBQLN3-mediated proteasome delivery is impaired
• Accumulation of ubiquitinated proteins
• Formation of stress granules and protein inclusions

TDP-43 Pathology

[ALS](/diseases/als) features [TDP-43 proteinopathy](/mechanisms/tdp-43-proteinopathy):

• UBQLN3 interacts with TDP-43 in inclusions
• May affect TDP-43 aggregation and clearance
• Disrupted proteostasis contributes to pathology

Frontotemporal Dementia

UBQLN3 is linked to [FTD](/diseases/frontotemporal-dementia) [rutherford2006](https://pubmed.ncbi.nlm.nih.gov/17053147/):

• UBQLN2 mutations cause ALS/FTD spectrum disease
• UBQLN3 expression is dysregulated in FTD brain
• Interaction with tau pathology in FTD

Parkinson's Disease

UBQLN3 may also play a role in [Parkinson's disease](/diseases/parkinsons-disease):

• Alpha-synuclein aggregation involves proteostasis disruption
• UBQLN3 may influence alpha-synuclein clearance
• Lewy bodies contain ubiquitinated proteins

Expression Patterns

Tissue Distribution

UBQLN3 shows tissue-specific expression:

• Testis: Highest expression (where it was initially discovered)
• Brain: Moderate expression, primarily in neurons
• Heart: Low-moderate expression
• Skeletal muscle: Lower expression
• Other tissues: Variable expression

Brain Regional Distribution

Within the brain, UBQLN3 is expressed in:

• [Cerebral cortex](/brain-regions/cortex): Pyramidal neurons
• [Hippocampus](/brain-regions/hippocampus): Dentate gyrus, CA regions
• [Brainstem](/brain-regions/brainstem): Motor nuclei
• [Spinal cord](/brain-regions/spinal-cord): Motor neurons

Cell Type Specificity

• Neurons: Primary expression in excitatory and inhibitory neurons
• Astrocytes: Lower expression
• Microglia: Minimal expression
• Oligodendrocytes: Variable expression

Therapeutic Implications

Targeting Protein Quality Control

Modulating UBQLN3 function represents a therapeutic strategy [anderson2020](https://pubmed.ncbi.nlm.nih.gov/32704153/), [davidson2018](https://pubmed.ncbi.nlm.nih.gov/29329244/):

Proteasome Enhancement

• Proteasome activators: Enhance proteasome function to compensate for impaired delivery
• Ubiquilin stabilizers: Promote UBQLN3 function
• Considerations: Must avoid excessive proteasome activation

Autophagy Enhancement

• mTOR inhibitors: Promote autophagy (rapamycin, etc.)
• Direct autophagy inducers: Beclin-1, ATG proteins
• Considerations: Balance autophagy vs. proteasome pathways

Aggregation Inhibition

• Aggregation inhibitors: Prevent protein aggregate formation
• Chaperone enhancement: Increase Hsp70/Hsp90 activity
• Considerations: Must target specific disease proteins

Drug Development Considerations

Existing Approaches

| Approach | Status | Application |
|----------|--------|-------------|
| Proteasome inhibitors | Approved (cancer) | Not suitable for neurodegeneration |
| Autophagy inducers | Preclinical | Being explored in ALS/PD |
| Chaperone modulators | Research | Promising approach |
| Gene therapy | Research | Viral vector delivery |

Animal Models

Ubiquilin Knockout Studies

• Ubqln2 knockout mice: Neonatal lethality
• Ubqln1 knockout: Viable with age-related phenotypes
• Conditional knockouts: Tissue-specific effects
• Transgenic models: Disease-relevant phenotypes

Disease Models

• ALS mouse models with UBQLN2 mutations show:
• Progressive motor dysfunction
• Proteasome impairment
• TDP-43 inclusions
• Premature death

Research Directions

Unresolved Questions

Emerging Areas

Cross-Links

Related Mechanisms

• [Protein Quality Control Network](/mechanisms/protein-quality-control-network)
• [Proteasome Function](/mechanisms/proteasome-function)
• [Autophagy in Neurodegeneration](/mechanisms/autophagy)
• [Protein Aggregation Mechanisms](/mechanisms/protein-aggregation-neurodegeneration)
• [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy)

Related Genes

• [UBQLN1 Gene](/genes/ubqln1) — Ubiquilin 1
• [UBQLN2 Gene](/genes/ubqln2) — Ubiquilin 2 (ALS-causing)
• [SQSTM1 Gene](/genes/sqstm1) — Sequestosome 1 (autophagy receptor)
• [VCP Gene](/genes/vcp) — Valosin-containing protein (ALS gene)

Related Diseases

• [Amyotrophic Lateral Sclerosis](/diseases/als)
• [Frontotemporal Dementia](/diseases/frontotemporal-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [NCBI Gene: UBQLN3](https://www.ncbi.nlm.nih.gov/gene/50628)
• [UniProt: Q9H7D9](https://www.uniprot.org/uniprot/Q9H7D9)
• [Ensembl: ENSG00000166394](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166394)
• [HGNC: UBQLN3](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:15694)

References